Showing results (31-40 of 296) with videos related to
Sort By:
Pageof 30
Cytokine|December 26, 2008
Inflammatory demyelinating events following treatment with anti-tumor necrosis factorA Fromont, J De Seze, M C Fleury, et al.Osteoarthritis and Cartilage|March 15, 2011
Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working GroupP G Conaghan, D J Hunter, J F Maillefert, et al.Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|May 25, 2012
Hybrid procedures as a novel technique in the treatment of critical limb ischemiaP-S Aho, M VenermoQJM : Monthly Journal of the Association of Physicians|June 29, 2000
Primary hyperparathyroidism with normal serum intact parathyroid hormone levelsC Mischis-Troussard, P Goudet, B Verges, et al.The Journal of Urology|March 19, 1999
Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinomaJ F Maillefert, J Sibilia, F Michel, et al.Revue Du Rhumatisme (English Ed.)|March 1, 1995
Bone tissue in rheumatoid arthritis (2). Pathophysiologic data, pathologic findings, and therapeutic implicationsB Cortet, R M Flipo, B Duquesnoy, et al.Osteoarthritis and Cartilage|December 31, 2003
Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis. A two-year prospective randomized controlled studyT Pham, J-F Maillefert, C Hudry, et al.Revue Du Rhumatisme (English Ed.)|March 20, 1999
Bone metastases from a paraganglioma. A review of five casesM Razakaboay, J F Maillefert, D Wendling, et al.Revue Du Rhumatisme (English Ed.)|March 1, 1995
Bone tissue in rheumatoid arthritis (1). Bone mineral density and fracture riskB Cortet, R M Flipo, B Duquesnoy, et al.La Revue De Medecine Interne|March 1, 1994
[Treatment of refractory rheumatoid arthritis with cyclosporine]R M Flipo, B Cortet, B Duquesnoy, et al.Pageof 30